Aastrom Biosciences, Inc. (VCEL)

Last Three Months

23-Aug-24 -- 22-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

33

0

0

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
15-Nov-24 4:05 PM View:	14-Nov-24 Option Sale ($943.78K)	Colangelo Dominick President and CEO Director		Aastrom Biosciences, Inc. - VCEL	0% 220.94K	0	0	--	--	Show Txns Hide Txns

15-Nov-24 4:05 PM View:	13-Nov-24 Option Sale ($388.78K)	McLaughlin Kevin F Director		Aastrom Biosciences, Inc. - VCEL	0% 11.9K	0	0	--	--	Show Txns Hide Txns

04-Oct-24 4:06 PM View:	02-Oct-24 Planned Option Sale ($235.36K)	Gilman Steven C Director		Aastrom Biosciences, Inc. - VCEL	0% 11.0K	0	0	--	--	Show Txns Hide Txns

05-Sep-24 4:05 PM View:	03-Sep-24 Planned Option Sale ($498.30K)	Hopper Jonathan Mark Chief Medical Officer		Aastrom Biosciences, Inc. - VCEL	0% 58.23K	0	0	--	--	Show Txns Hide Txns